1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus
Centers For Disease Control And Prevention (Usa).
Morbidity and Mortality Weekly Report 44(RR4): 1-11
1995
DOI: 10.2307/42000580Document Number: 208129
Document emailed within 0-6 h
Related Documents
Goodwin, S.D. 1993: Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children PharmacoTherapy 13(6): 640-646Thea, D.M.; Lambert, G.; Weedon, J.; Matheson, P.B.; Abrams, E.J.; Bamji, M.; Straus, W.L.; Thomas, P.A.; Krasinski, K.; Heagarty, M. 1996: Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. new York City Perinatal HIV Transmission Collaborative Study Group Pediatrics 97(1): 59-64
Buskin, S.E.; Newcomer, L.M.; Koutsky, L.A.; Hooton, T.M.; Spach, D.H.; Hopkins, S.G. 1999: Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 20(2): 201-206
Boudes, P. 1991: Practical utility of lactate dehydrogenase in the diagnosis of human immunodeficiency virus-related Pneumocystis carinii pneumonia Archives of Internal Medicine 151(1): 198
Ruffini, D.D.; Madhi, S.A. 2002: The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia Aids 16(1): 105-112
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Oka, M.; Noguchi, Y.; Matsumoto, Y.; Tsurukawa, Y.; Kawano, K.; Araki, J.; Mine, Y.; Kanda, T.; Saito, A.; Hara, K. 1985: Five cases of Pneumocystis carinii pneumonia diagnosed by bronchofiberscopy--the usefulness of the bronchoalveolar lavage for diagnosis of Pneumocystis carinii pneumonia Nihon Kyobu Shikkan Gakkai Zasshi 23(9): 1052-1058
Caldwell, M.B.; Mascola, L.; Smith, W.; Thomas, P.; Hsu, H.W.; Maldonado, Y.; Parrott, R.; Byers, R.; Oxtoby, M. 1992: Biologic, foster, and adoptive parents: care givers of children exposed perinatally to human immunodeficiency virus in the United States. the Pediatric Spectrum of Disease Clinical Consortium Pediatrics 90(4): 603-607
Dutz, W.; Post, C.; Jennings-Khodadad, E.; Fakouhi, T.; Kohout, E.; Bandarizadeh, B. 1976: Therapy and prophylaxis of Pneumocystis carinii pneumonia National Cancer Institute Monograph 43: 179-185
O'Doherty, M.J.; Bateman, N.T. 1991: Prophylaxis and treatment of Pneumocystis carinii pneumonia British Journal of Hospital Medicine 45(5): 277-8 280 283
Lozano, F.; Lozano, M.C.; Sánchez, A.; León, E.; García-Bragado, F. 1993: Haemophilus influenzae pneumonia simulating Pneumocystis carinii pneumonia in an HIV-infected patient Enfermedades Infecciosas y Microbiologia Clinica 11(5): 287-288
Rosen, M.J.; Tow, T.W.; Chuang, M.T.; Teirstein, A.S. 1984: Prognosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome Annals of Internal Medicine 101(2): 276
Saah, A.J.; Hoover, D.R.; Peng, Y.; Phair, J.P.; Visscher, B.; Kingsley, L.A.; Schrager, L.K. 1995: Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study JAMA 273(15): 1197-1202
Machiels, G.; Urban, M.I. 1992: Pneumocystis carinii as a cause of pneumonia in HIV-infected patients in Lusaka, Zambia Transactions of the Royal Society of Tropical Medicine and Hygiene 86(4): 399-400
Nakasato, S.K.; Pham, T.T.; Berman, S.M. 1991: Impact of treatment guidelines on the use of aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia American Journal of Hospital Pharmacy 48(11): 2440-2442
del Rio, C.; Guarner, J.; Honig, E.G.; Slade, B.A. 1988: Sputum examination in the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 112(12): 1229-1232
Birungi, H.; Mugisha, J.F.; Obare, F.; Nyombi, J.K. 2009: Sexual behavior and desires among adolescents perinatally infected with human immunodeficiency virus in Uganda: implications for programming Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 44(2): 184-187
Monforte, A.D.; Mainini, F.; Bini, T.; Moscatelli, G.C.; Antinori, S.; Formenti, T.; Testa, L.; Mena, M.; Moroni, M. 1995: Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS Journal of ChemoTherapy 7(Suppl): 184-186
Kitchin, O.P.; Masekela, R.; Becker, P.; Moodley, T.; Risenga, S.M.; Green, R.J. 2012: Outcome of human immunodeficiency virus-exposed and -infected children admitted to a pediatric intensive care unit for respiratory failure Pediatric Critical Care Medicine: a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 13(5): 516-519